Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

David Ellingson , Lauren Abrey , Sarah Nelson , Timothy Kaufmann , Josep Garcia , Olivier Chinot (1) , Frank Saran , Ryo Nishikawa , Roger Henriksson (2) , Warren Mason , Wolfgang Wick (3) , Nicholas Butowski , Keith Ligon (4) , Elizabeth R Gerstner (5) , Howard Colman , John de Groot , Susan Chang , Ingo Mellinghoff , Robert Marr Young (6) , Brian Alexander , Rivka Colen , Jennie Taylor , Isabel Arrillaga-Romany , David Mehta , Raymond Huang , David Pope (7) , David Reardon , Tracy Batchelor (5) , Michael Prados , Evanthia Galanis (8) , Patrick Wen , Timothy Cloughesy

1 Département de neurooncologie
2 Department of Radiation Sciences, Oncology
3 Department of Neurooncology
4 Hadassah Hebrew University Medical Center [Jerusalem]
5 Massachusetts General Hospital [Boston]
6 Loughborough University
7 School of Environment and Technology
8 Department of Molecular Medicine

Domains: Life Sciences [q-bio]

David Ellingson, Lauren Abrey, Sarah Nelson, Timothy Kaufmann, Josep Garcia, et al.. Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro-Oncology, 2018, ⟨10.1093/neuonc/noy053⟩. ⟨hal-01814367⟩